Skip to content
10-K

Annual Report

Nuo Therapeutics, Inc. AURX

0001437749-26-010360

← back to feed
Filed
Mar 30, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 26, 2026 48.29M sh
Capex FY 2025 · Dec 31, 2025 $274.76K
Capex FY 2025 · Dec 31, 2024 $154.96K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$864.97K
Operating Cash Flow FY 2025 · Dec 31, 2024 −$2.23M
Cash And Equivalents FY 2025 · Dec 31, 2025 $548.95K
Cash And Equivalents FY 2025 · Dec 31, 2024 $283.71K
Stockholders Equity FY 2025 · Dec 31, 2025 −$956.56K
Stockholders Equity FY 2025 · Dec 31, 2024 $513.71K
Stockholders Equity FY 2025 · Dec 31, 2023 $1.04M
Current Liabilities FY 2025 · Dec 31, 2025 $1.31M
Current Liabilities FY 2025 · Dec 31, 2024 $578.45K
Total Liabilities FY 2025 · Dec 31, 2025 $2.8M
Total Liabilities FY 2025 · Dec 31, 2024 $675.8K
Current Assets FY 2025 · Dec 31, 2025 $1.38M
Current Assets FY 2025 · Dec 31, 2024 $841.55K
Total Assets FY 2025 · Dec 31, 2025 $1.85M
Total Assets FY 2025 · Dec 31, 2024 $1.19M
Eps Basic FY 2025 · Dec 31, 2025 −$0.05
Eps Basic FY 2025 · Dec 31, 2024 −$0.05
Sga Expense FY 2025 · Dec 31, 2025 $4.73M
Sga Expense FY 2025 · Dec 31, 2024 $3.52M
Net Income FY 2025 · Dec 31, 2025 −$2.51M
Net Income FY 2025 · Dec 31, 2024 −$2.32M
Operating Income FY 2025 · Dec 31, 2025 −$2.52M
Operating Income FY 2025 · Dec 31, 2024 −$2.46M
Gross Profit FY 2025 · Dec 31, 2025 $2.22M
Gross Profit FY 2025 · Dec 31, 2024 $1.06M
Stock Issued FY 2025 · Jul 31, 2025 527.61K sh